Bella Intimates

Bella Intimates

Social Isolation may lead to Poor Survival Rates in Breast Cancer Patients
Essentially Women • May 18, 2023

Social Isolation may lead to Poor Survival Rates in Breast Cancer Patients

Breast cancer is the most common form of cancer, affecting women worldwide. Although the survival rate is very high when the disease is discovered early, new research suggests that having a large social network might also affect a person's chances of survival.

Having more social ties may lead to higher survival rates, new study finds.

Breast cancer affects hundreds of thousands of women around the world each year. In the United States alone 246,660 women are estimated to receive a breast cancer diagnosis every year. That is 1 in every 8 women. Around 40,000 American women die of breast cancer every year. However, breast cancer survival rates look encouraging, especially if the disease is detected early.

Since 1990, breast cancer survival rates have been increasing. Due to better screening practices, increased public awareness and early detection, and improved technology and treatments, mortality in women aged 50 and older has been declining significantly for the past 2 decades.

In the U.S. there are currently over 2.8 million breast cancer survivors.

What Signs of Breast Cancer are there other than a Lump
by Essentially Women 18 May, 2023
A breast lump or mass is just one of the possible signs of breast cancer in women or men. Breast cancer can cause serveral additional changes to the skin on and around the breast. Anyone who notices any of these changes should see a doctor.
What to Know About Menopause and Sore Breasts
by Essentially Women 18 May, 2023
A person reaches menopause after 12 months without having a period. This stage follows a transitional period called perimenopause, where estrogen and progesterone levels in the body fluctuate unpredictably.
New Potential Treatment Option for Triple Negative Breast Cancer
by Essentially Women 18 May, 2023
In a recent study published in the Journal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndrome may be useful to treat triple-negative breast cancer, which is one of the most aggressive and lethal types of breast cancer.
View More Articles
Share by: